AKT1 and breast carcinoma: Mahiro Iizuka-Ohashi et al. found that the lipophilic statins simvastatin and fluvastatin can inhibit the activation of AKT in breast cancer cells, thereby inducing apoptosis to inhibit tumor progression [37].